Fundraising Fox

Kate Bingham

Investor

Managing Partner at SV Health Investors

London, England, United Kingdom

Writes $30K – $3M checks Β· typically $1.5M

About

Kate Bingham co-leads the biotech franchise at SV Health Investors, focusing on drug discovery and development companies across the UK, EU, and US, and has led many of the firm's company-creation investments. She chaired the UK Vaccine Taskforce, for which she was awarded a DBE in 2021, and holds a first class degree in Biochemistry from the University of Oxford and an MBA from Harvard Business School. She also serves on the boards of the Francis Crick Institute and ARIA.

ContactΒ· self-published, not guessed

Invests in

Biotech

Experience

  1. SV Health InvestorsManaging Partnercurrent1991 β€” presentLondon, United Kingdom
  2. UK Vaccine Taskforce 2020Chairman2020

Colleagues at SV Health Investors

Frequently asked questions

Who is Kate Bingham?
Kate Bingham co-leads the biotech franchise at SV Health Investors, focusing on drug discovery and development companies across the UK, EU, and US, and has led many of the firm's company-creation investments. She chaired the UK Vaccine Taskforce, for which she was awarded a DBE in 2021, and holds a first class degree in Biochemistry from the University of Oxford and an MBA from Harvard Business School. She also serves on the boards of the Francis Crick Institute and ARIA.
Where does Kate Bingham work?
Kate Bingham is Managing Partner at SV Health Investors.
What does Kate Bingham invest in?
Kate Bingham invests in Biotech.
What check size does Kate Bingham write?
Kate Bingham typically writes checks of $30K – $3M.
Where did Kate Bingham go to school?
Kate Bingham studied at Harvard Business School (MBA, Business); University of Oxford (BA, Biochemistry).

Same school